Robertson J, Loviny T L, Goedert M, Jakes R, Murray K J, Anderton B H, Hanger D P
Department of Neuroscience, Institute of Psychiatry, London, UK.
Dementia. 1993 Sep-Oct;4(5):256-63. doi: 10.1159/000107331.
Alzheimer's disease paired helical filaments contain abnormally phosphorylated tau (PHF-tau) which has reduced electrophoretic mobility on sodium dodecyl sulphate polyacrylamide electrophoresis. We have investigated the effects of cyclic-AMP-dependent protein kinase (PKA) on recombinant human tau isoforms and two recombinant tau fragments. PKA phosphorylated tau and reduced its electrophoretic mobility, phosphorylation towards the C-terminus of tau having a major influence on this property. Substitution of serine396 (phosphorylated in PHF-tau) or serine416 (phosphorylated by calcium/calmodulin kinase II) by alanine demonstrated that these are not major sites for PKA phosphorylation. Although the phosphorylated forms of tau generated by PKA are not identical to those of PHF-tau, PKA may be involved in the generation of PHF-tau in Alzheimer's disease via phosphorylation of additional, as yet unidentified, sites on tau.
阿尔茨海默病的双螺旋丝包含异常磷酸化的tau蛋白(PHF-tau),其在十二烷基硫酸钠聚丙烯酰胺凝胶电泳上的电泳迁移率降低。我们研究了环磷酸腺苷依赖性蛋白激酶(PKA)对重组人tau异构体和两个重组tau片段的影响。PKA使tau蛋白磷酸化并降低其电泳迁移率,tau蛋白C末端的磷酸化对此特性有主要影响。将丝氨酸396(在PHF-tau中磷酸化)或丝氨酸416(被钙/钙调蛋白激酶II磷酸化)替换为丙氨酸表明,这些不是PKA磷酸化的主要位点。尽管PKA产生的磷酸化tau形式与PHF-tau不同,但PKA可能通过磷酸化tau上其他尚未确定的位点参与阿尔茨海默病中PHF-tau的产生。